MSCs Conditioned Media and Umbilical Cord Blood Plasma Metabolomics and Composition

Human mesenchymal stem cells (hMSCs) from umbilical cord (UC) blood (UCB) and matrix are tested clinically for a variety of pathologies but in vitro expansion using culture media containing fetal bovine serum (FBS) is essential to achieve appropriate cell numbers for clinical use. Human UCB plasma (hUCBP) can be used as a supplement for hMSCs culture, since UCB is rich in soluble growth factors and due to worldwide increased number of cryopreserved UCB units in public and private banks, without the disadvantages listed for FBS. On the other hand, the culture media enriched in growth factors produced by these hMSCs in expansion (Conditioned medium - CM) can be an alternative to hMSCs application. The CM of the hMSCs from the UC might be a better therapeutic option compared to cell transplantation, as it can benefit from the local tissue response to the secreted molecules without the difficulties and complications associated to the engraftment of the allo- or xeno-transplanted cells. These facts drove us to know the detailed composition of the hUCBP and CM, by 1H-NMR and Multiplexing LASER Bead Technology. hUCBP is an adequate alternative for the FBS and the CM and hUCBP are important sources of growth factors, which can be used in MSCs-based therapies. Some of the major proliferative, chemotactic and immunomodulatory soluble factors (TGF-β, G-CSF, GM-CSF, MCP-1, IL-6, IL-8) were detected in high concentrations in CM and even higher in hUCBP. The results from 1H-NMR spectroscopic analysis of CM endorsed a better understanding of hMSCs metabolism during in vitro culture, and the relative composition of several metabolites present in CM and hUCBP was obtained. The data reinforces the potential use of hUCBP and CM in tissue regeneration and focus the possible use of hUCBP as a substitute for the FBS used in hMSCs in vitro culture.

[1]  P. Bártolo,et al.  Effects of Human Mesenchymal Stem Cells Isolated from Wharton's Jelly of the Umbilical Cord and Conditioned Media on Skeletal Muscle Regeneration Using a Myectomy Model , 2014, Stem cells international.

[2]  T. Pereira,et al.  Effects of umbilical cord tissue mesenchymal stem cells (UCX®) on rat sciatic nerve regeneration after neurotmesis injuries , 2014, Journal of stem cells & regenerative medicine.

[3]  G. Solcan,et al.  The 1H NMR Profile of Healthy Dog Cerebrospinal Fluid , 2013, PloS one.

[4]  A. Salgado,et al.  Unveiling the effects of the secretome of mesenchymal progenitors from the umbilical cord in different neuronal cell populations. , 2013, Biochimie.

[5]  D. S. Li,et al.  Human umbilical cord-derived MSC culture: the replacement of animal sera with human cord blood plasma , 2013, In Vitro Cellular & Developmental Biology - Animal.

[6]  J. Gimble,et al.  Human mesenchymal stem cells from the umbilical cord matrix: successful isolation and ex vivo expansion using serum-/xeno-free culture media. , 2013, Biotechnology journal.

[7]  T. Pereira,et al.  Mesenchymal Stem Cells from Extra-Embryonic Tissues for Tissue Engineering – Regeneration of the Peripheral Nerve , 2013 .

[8]  T. Pereira,et al.  Biomaterials and Stem Cell Therapies for Injuries Associated to Skeletal Muscular Tissues , 2013 .

[9]  A. Attar,et al.  Parameters that influence the isolation of multipotent mesenchymal stromal cells from human umbilical cord blood. , 2013, Hematology/oncology and stem cell therapy.

[10]  M. Simionescu,et al.  Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro. , 2013, Stem cells and development.

[11]  M. Choolani,et al.  Human Wharton’s Jelly Stem Cell Conditioned Medium Enhances Freeze-Thaw Survival and Expansion of Cryopreserved CD34+ Cells , 2013, Stem Cell Reviews and Reports.

[12]  D. Peterson,et al.  Human Mesenchymal Stem Cell Grafts Enhance Normal and Impaired Wound Healing by Recruiting Existing Endogenous Tissue Stem/Progenitor Cells , 2013, Stem cells translational medicine.

[13]  A. Varejão,et al.  Use of poly(DL-lactide-ε-caprolactone) membranes and mesenchymal stem cells from the Wharton's jelly of the umbilical cord for promoting nerve regeneration in axonotmesis: in vitro and in vivo analysis. , 2012, Differentiation; research in biological diversity.

[14]  T. Pereira,et al.  Use of hybrid chitosan membranes and human mesenchymal stem cells from the Wharton jelly of umbilical cord for promoting nerve regeneration in an axonotmesis rat model★ , 2012, Neural regeneration research.

[15]  C. V. van Blitterswijk,et al.  Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. , 2012, Tissue engineering. Part B, Reviews.

[16]  Jeffrey M Karp,et al.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. , 2012, Cell stem cell.

[17]  S. Wen,et al.  Associations among birth weight, placental weight, gestational period and product quality indicators of umbilical cord blood units. , 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[18]  A. Salgado,et al.  Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine. , 2011, Current stem cell research & therapy.

[19]  K. Cherian,et al.  “Humanized” Stem Cell Culture Techniques: The Animal Serum Controversy , 2011, Stem cells international.

[20]  M. Stojkovic,et al.  Characterisation of Human Embryonic Stem Cells Conditioning Media by 1H-Nuclear Magnetic Resonance Spectroscopy , 2011, PloS one.

[21]  L. Griffith,et al.  Growth factor regulation of proliferation and survival of multipotential stromal cells , 2010, Stem Cell Research & Therapy.

[22]  Daniel Raftery,et al.  Advances in NMR-based biofluid analysis and metabolite profiling. , 2010, The Analyst.

[23]  Gen Suzuki,et al.  Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair. , 2009, Biochemical and biophysical research communications.

[24]  Joo-Young Jung,et al.  Mesenchymal stromal cells expanded in human allogenic cord blood serum display higher self-renewal and enhanced osteogenic potential. , 2009, Stem cells and development.

[25]  Yao Zhang,et al.  Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure , 2009, Molecular Biology Reports.

[26]  L. Chung,et al.  HRMAS 1H‐NMR measured changes of the metabolite profile as mesenchymal stem cells differentiate to targeted fat cells in vitro: implications for non‐invasive monitoring of stem cell differentiation in vivo , 2008, Journal of tissue engineering and regenerative medicine.

[27]  S Geuna,et al.  Use of hybrid chitosan membranes and N1E-115 cells for promoting nerve regeneration in an axonotmesis rat model. , 2008, Biomaterials.

[28]  J. Winnike,et al.  High-throughput nuclear magnetic resonance metabolomic footprinting for tissue engineering. , 2008, Tissue engineering. Part C, Methods.

[29]  Liwen Chen,et al.  Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing , 2008, PloS one.

[30]  K. Ballen,et al.  Collection and preservation of cord blood for personal use. , 2008, Biology of Blood and Marrow Transplantation.

[31]  J. Lindon,et al.  NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. , 2008, Chemical research in toxicology.

[32]  C. Cetrulo,et al.  Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[33]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[34]  U. Günther,et al.  Chapter 2:1D and 2D NMR Spectroscopy: From Metabolic Fingerprinting to Profiling , 2007 .

[35]  T. Ebbels,et al.  Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts , 2007, Nature Protocols.

[36]  P. Ljungman,et al.  Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells , 2007, Leukemia.

[37]  V. Tanavde,et al.  Human umbilical cord blood serum can replace fetal bovine serum in the culture of mesenchymal stem cells , 2007, Cell biology international.

[38]  Paulo Michel Roehe,et al.  Nanobacteria-like particles: a threat to cell cultures , 2007 .

[39]  A. Hardikar,et al.  Human umbilical cord blood serum promotes growth, proliferation, as well as differentiation of human bone marrow-derived progenitor cells , 2006, In Vitro Cellular & Developmental Biology - Animal.

[40]  A. Caplan,et al.  Mesenchymal stem cells as trophic mediators , 2006, Journal of cellular biochemistry.

[41]  Elaine Holmes,et al.  Impact of analytical bias in metabonomic studies of human blood serum and plasma. , 2006, Analytical chemistry.

[42]  Hanns-Ulrich Marschall,et al.  Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease , 2006, Transplantation.

[43]  N. Heaton,et al.  Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. , 2005, Analytical chemistry.

[44]  F. Malz,et al.  Validation of quantitative NMR. , 2005, Journal of pharmaceutical and biomedical analysis.

[45]  Elaine Holmes,et al.  Biochemical characterization of rat intestine development using high-resolution magic-angle-spinning 1H NMR spectroscopy and multivariate data analysis. , 2005, Journal of proteome research.

[46]  Andrea Bacigalupo,et al.  Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[47]  H. Okano,et al.  Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. , 2004, Blood.

[48]  M. Pittenger,et al.  Mesenchymal stem cells and their potential as cardiac therapeutics. , 2004, Circulation research.

[49]  Shu-Ching Hsu,et al.  Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[50]  Frank P Barry,et al.  Stem cell therapy in a caprine model of osteoarthritis. , 2003, Arthritis and rheumatism.

[51]  D. Butler,et al.  Repair of patellar tendon injuries using a cell–collagen composite , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[52]  R. Deans,et al.  Mesenchymal stem cells: biology and potential clinical uses. , 2000, Experimental hematology.

[53]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[54]  R Cancedda,et al.  Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. , 2000, Journal of cell science.

[55]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[56]  K. Kraus,et al.  Mesenchymal stem cells in osteobiology and applied bone regeneration. , 1998, Clinical orthopaedics and related research.

[57]  B. P. Smith,et al.  Cartilage injuries: a review of 31,516 knee arthroscopies. , 1997, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[58]  J. Listinsky Biomolecular NMR Spectroscopy , 1997 .

[59]  R. Walker,et al.  Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. , 1997, Blood.

[60]  D. Barritault,et al.  Growth factors in skeletal muscle regeneration. , 1996, Cytokine & growth factor reviews.

[61]  J. Kurtzberg,et al.  Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. , 1996, The New England journal of medicine.

[62]  Jeremy N. S. Evans Biomolecular NMR Spectroscopy , 1995 .

[63]  M. Spraul,et al.  750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. , 1995, Analytical chemistry.

[64]  S. Glaser,et al.  A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients , 1994, Journal of biomolecular NMR.

[65]  Paul A. Keifer,et al.  Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity , 1992 .

[66]  P. Wright,et al.  Sensitivity improvement in proton-detected two-dimensional heteronuclear correlation NMR spectroscopy , 1991 .

[67]  Ad Bax,et al.  MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy , 1985 .

[68]  A. Friedenstein,et al.  THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS , 1970, Cell and tissue kinetics.

[69]  W. Russell,et al.  The Principles of Humane Experimental Technique , 1960 .

[70]  Todd C McDevitt,et al.  Stem cell paracrine actions and tissue regeneration. , 2010, Regenerative medicine.

[71]  Jürgen Frank,et al.  Serum-free cell culture: the serum-free media interactive online database. , 2010, ALTEX.

[72]  H. Koo,et al.  Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. , 2009, Cellular immunology.

[73]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[74]  John C. Lindon,et al.  NMR Spectroscopy of Biofluids , 1999 .

[75]  P. Knowles Biomolecular NMR spectroscopy: By J N S Evans. P 444. Oxford University Press, Oxford. 1995 ISBN , 1996 .

[76]  S. Bolin,et al.  Viral contamination of fetal bovine serum used for tissue culture: risks and concerns. , 1991, Developments in biological standardization.

[77]  G. Bodenhausen,et al.  Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy , 1980 .